From Antilymphocyte Serum to Therapeutic Monoclonal Antibodies: First Experiences with a Chimeric CD4 Antibody in the Treatment of Autoimmune Disease

Immunological Reviews

Volumn 129, Issue 1, 1992, Pages 81-104

  Riethmuuller, Gert ^a   Rieber, Ernst Peter ^a   Kiefersauer, Stefan ^a   Prinz, Jourg ^a   Lubbe, Petervander ^b   Meiser, Bruno ^c   Breedveld, Ferdy ^a   Eisenburg, Josef ^d   Kruuger, Klaus ^a   Deusch, Kai ^e   Sanders, Martin ^f   Reiter, Christian ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d KRANKENHAUS BARMHERZIGE BRÜDER   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f Universitat Munchen ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD4 ANTIGEN; CORTICOSTEROID; CYCLOSPORIN A; MONOCLONAL ANTIBODY; CHIMERIC PROTEIN; LYMPHOCYTE ANTIBODY;

AUTOIMMUNITY; CROHN DISEASE; DRUG THERAPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; ANIMAL; AUTOIMMUNE DISEASE; IMMUNOLOGY;

ANIMAL; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ANTILYMPHOCYTE SERUM; AUTOIMMUNE DISEASES; CHIMERIC PROTEINS; HUMAN; T-LYMPHOCYTES;

EID: 0026613779     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1992.tb01420.x     Document Type: Article

References (55)

1. Immunohistological studies of surface antigen on colonic lymphoid cells in normal and inflamed mucosa
2. Imraunologically mediated regression of a murine lymphoma following treatment with anti‐L3T4 antibody
3. The biologic role of CD2, CD4 and CD8 in T cell activation
4. A placebo‐controlled, double‐blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N
5. Nuclear factor of activated T cells contains Fos and Jun
6. Autoimmunity. microbial immunity and the immunologic homunculus
7. Antibody and HIV‐1 gpl20 recognition of CEM undermines the concept of mimicry between antibodies and receptors
8. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody Gkl.5: similarity of L3T4 to human Leu‐3/T4 molecule. J
9. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus‐specific mRNA
10. Enhanced expression of HLA‐Class II molecules on activated human T lymphocytes following treatment with tumor necrosis factor alpha
11. Interaction between CD4 and class II MHC molecular mediated cell adhesion
12. Veto cells
13. Induction of immune tolerance by administration of monoclonal antibody to L3T4
14. Anti‐CD4 antibody treatment of patients with rheumatoid arthritis: I. effect on clinical course and circulating T cells
15. Monoclonal anti‐CD4 in arthritis
16. Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibody
17. Towards a network theory of the immune system
18. Therapeutische CD4‐T Zelldepletion mit Hilfe chimärischer, monoklonaler CD4‐Antikörper zur Therapie der autoimmunen, chronischen Hepatitis
19. Continuos cultures of fused cells secreting antibody of predefined specificity
20. Identification of a CD4 binding site of the β2 domain of HLA‐DR molecules
21. Etudes sur la resorption de cellules
22. Anti‐CD4 monoclonal antibody administration in renal transplanted patients
23. Death of mature T cells by separate ligation of CD4 and the T cell receptor for antigen
24. CD4 antibody treatment of severe psoriasis
25. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants
26. Specific killing of cytotoxic T cells and antigen‐presenting cells by CD4* cytotoxic T cell clones
27. Stem cell recovery from cyclophosphamide‐induced myelosuppression requires the presence of CD4* cells
28. Immunochemical analysis of the surface of the sea uchin egg – an approch to the study of fertilization
29. Chimaeric CD4 moniclonal antibody in treatment of generalised postular psoriasis
30. Veto function in vitro and in vivo
31. Treatment of Rheumatoid Arthritis with Monoclonal CD4 Antibody M‐T151
32. Differential manipulation of T cell functions by a panel of monoclonal CD4 antibodies
33. Anti‐CD4 abrogates rejection and reestablished long‐term tolerance to syngeneic newborn hearts grafted in mice chronically infected with trypanosoma cruzi
34. Monoclonal CD4 antibodies after accidental HIV infection
35. Antilymphocyte serum
36. In vivo and in vitro properties of intact and pepsin‐digested heterologous anti‐mouse thymus antibodies
37. High incidence of horse serum protein allergy in various autoimmune disorders
38. The CD4 receptor is complexed in detergent lysates to a protein‐tyrosine kinase (pp58) from human T lymphocytes
39. CD4 monoclonal antibodies in organ transplantation ‐ a review of progress
40. Signal for T‐cell differentiation to a CD4 cell lineage is delivered by CD4 transmembrane region and/or cytoplasmic tail
41. Anti‐CD4 monoclonal antibody for relapsing polychondritis
42. Experimental allergic encephalomyelitis in rhesus monkeys: II. Treatment of EAE with anti‐T lymphocyte subset monoclonal antibodies
43. The use of specific “lymphocyte” antisera to inhibit hypersensitive reactions of the “delayed” type
44. Manipulation of T cell responses with monoclonal antibodies
45. Anti‐CD4 antibody treatment of patients with rheumatoid arthritis: II. effect of in vivo treatment on in vitro proliferative response of CD4 cells
46. Atomic structure of a fragment of human CD4 containing two immunoglobulin‐like domains
47. Therapeutic use of monoclonal anti CD4 antibody in rheumatoid arthritis
48. Succesful treatment of autoimmunity in N2B/N2W Fl mice with monoclonal antibody to L3T4
49. Class II (DR) antigen expression on CD8* lymphocyte subsets in acquired immune deficiency (AIDS)